Lifevantage (LFVN) Director Increases Stake to 117,217 Shares with 450-Share Purchase

Rhea-AI Filing Summary

Darwin Lewis, a director of Lifevantage Corp (LFVN), reported an automatic purchase of common stock under a Rule 10b5-1 trading plan. On 09/16/2025 he acquired 450 shares at a price of $10.8499 per share, bringing his total beneficial ownership to 117,217 shares. The filing states the 10b5-1 plan was adopted on February 10, 2025. The Form 4 was signed on behalf of Mr. Lewis by a power of attorney on 09/18/2025. The report lists the transaction as a non-derivative acquisition and identifies Mr. Lewis as a director of the issuer.

Positive

• Transaction executed under a disclosed Rule 10b5-1 plan, which clarifies scheduling and reduces concerns about trading on material nonpublic information
• Complete disclosure of trade details: date (09/16/2025), price ($10.8499), shares acquired (450), and post-transaction beneficial ownership (117,217)

Negative

• None.

Insights

Securities Analyst

TL;DR: Director purchased 450 shares via an established 10b5-1 plan, increasing beneficial ownership to 117,217 shares.

The transaction is a routine insider purchase executed under a pre-existing Rule 10b5-1 plan adopted on February 10, 2025. The acquisition of 450 shares at $10.8499 is small relative to the reported post-transaction holding but is material to insider disclosure rules because it updates beneficial ownership. Execution under a 10b5-1 plan indicates the purchase was pre-scheduled rather than opportunistic trading based on contemporaneous material nonpublic information. The Form 4 was signed by a power of attorney on 09/18/2025.

Corporate Governance Expert

TL;DR: Filing documents compliant insider activity; 10b5-1 plan adoption is disclosed and a POA signature is used.

The filing clearly identifies the reporting person as a director and discloses the 10b5-1 plan adoption date (02/10/2025), providing governance transparency. The placement of the trade as non-derivative and the precise price ($10.8499) and share count (450) fulfill Section 16 reporting requirements. Signature by a power of attorney on 09/18/2025 is noted, and the report lists beneficial ownership following the trade as 117,217 shares. No additional governance issues or deviations are stated in the document.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Lewis Darwin

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2025		P(1)		450	A	$10.8499	117,217	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The purchases reported in this Form 4 were effected by an automatic purchase pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 10, 2025.

Remarks:

	/s/ Alissa Neufeld, Power of Attorney for Darwin Lewis	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Lifevantage director Darwin Lewis report on Form 4 (LFVN)?

He reported an acquisition of 450 shares of common stock on 09/16/2025 at a price of $10.8499, increasing his beneficial ownership to 117,217 shares.

Was the purchase by Darwin Lewis part of a 10b5-1 trading plan?

Yes. The Form 4 states the purchases were effected automatically pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2025.

Who signed the Form 4 for Darwin Lewis?

The Form 4 was signed by Alissa Neufeld, Power of Attorney for Darwin Lewis on 09/18/2025.

How is Darwin Lewis related to Lifevantage Corp as reported in the filing?

The filing identifies Darwin Lewis as a Director of Lifevantage Corp (LFVN).

Does the Form 4 report any derivative transactions for Darwin Lewis?

No. The Form 4 lists a non-derivative common stock acquisition and contains no derivative securities transactions.